XULANE 35 ug/d

XULANE 35 ug/d is a transdermal patch containing norelgestromin and ethinyl estradiol. It is used for contraception and hormone therapy. This patch is designed for convenient, once-weekly application.

XULANE 35 ug/d is primarily used for contraception and hormone therapy. The patch delivers a combination of hormones through the skin to prevent ovulation and provide birth control. It is also used to manage symptoms associated with hormonal imbalances, such as irregular periods or hormonal acne. The patch is applied once a week for three weeks, followed by a week without a patch.

Common effects of XULANE 35 ug/d may include skin irritation at the application site, breast tenderness, headaches, and nausea. Some users may experience changes in menstrual bleeding patterns. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

XULANE 35 ug/d should be handled with care to avoid skin irritation. The patch should be applied to clean, dry skin and changed weekly as directed. Avoid exposing the patch to excessive heat or sunlight. It is important to follow the prescribed schedule to maintain effectiveness. Always consult a healthcare provider before starting or stopping any hormonal therapy.

XULANE 35 ug/d may interact with certain medications, including antibiotics, anticonvulsants, and antifungal drugs. Alcohol and other substances that affect liver enzymes may also impact the effectiveness of the patch. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions.